Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Swissmedic approves Celgene's Revlimid

Nov. 23, 2011

New steroidal lactones from M. crassissima disclosed by PharmaMar

Nov. 23, 2011

Bendamustine evaluated in anaplastic glioma

Nov. 23, 2011

Cabozantinib trial begins in hormone receptor-positive breast cancer

Nov. 22, 2011

Merrimack Pharmaceuticals begins enrollment in MM-121/erlotinib combination trial

Nov. 22, 2011

FDA approves Erwinaze for acute lymphoblastic leukemia

Nov. 22, 2011

Maximum tolerated dose of LDE-225 determined in patients with solid tumors

Nov. 22, 2011

FDA reaches final decision on Avastin for metastatic breast cancer

Nov. 21, 2011

Mologen's phase I/II study of cell-based renal cancer therapy meets primary endpoint

Nov. 21, 2011

AstraZeneca receives positive CHMP opinion for vandetanib

Nov. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...